English
简体中文
Total: £ 56.28
Published Date: 2025-07-17 | Pages: 85 | Tables: 84 | Medical Care
The global market for Oncology-based In-vivo CRO was valued at US$ 1324 million in the year 2024 and is projected to reach a revised size of US$ 2688 million by 2031, growing at a CAGR of 10.4% during the forecast period.
Oncology-based In-vivo CRO refers to specialized contract research organizations that provide preclinical in-vivo services focused on cancer drug development. These CROs conduct animal model studies to evaluate the efficacy, toxicity, pharmacokinetics, and mechanisms of anticancer drugs. They utilize xenograft models (e.g., cell line-derived xenografts, patient-derived xenografts), genetically engineered mouse models, orthotopic tumor models, and metastasis models to simulate human cancer biology. Such services are essential for pharmaceutical companies and biotech firms seeking to accelerate oncology R&D pipelines while minimizing infrastructure investment and regulatory risk.
North American market for Oncology-based In-vivo CRO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Oncology-based In-vivo CRO is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Oncology-based In-vivo CRO in Pharmaceutical Companies is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Oncology-based In-vivo CRO include Charles River Laboratories, ICON, WuXi AppTec, Crown Bioscience, Labcorp Drug Development, Eurofins Scientific, Taconic Biosciences, The Jackson Laboratory, Evotec, Champions Oncology, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oncology-based In-vivo CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology-based In-vivo CRO.
The Oncology-based In-vivo CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oncology-based In-vivo CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oncology-based In-vivo CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
ICON
WuXi AppTec
Crown Bioscience
Labcorp Drug Development
Eurofins Scientific
Taconic Biosciences
The Jackson Laboratory
Evotec
Champions Oncology
Thermo Fisher Scientific
IMV
Pharmaron
Living Tumor Laboratory
Segment by Type
Efficacy Evaluation
Combination Therapy Testing
Tumor Immune Microenvironment Assessment
Others
Segment by Application
Pharmaceutical Companies
Academic and Research Institutions
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oncology-based In-vivo CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology-based In-vivo CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Efficacy Evaluation
1.2.3 Combination Therapy Testing
1.2.4 Tumor Immune Microenvironment Assessment
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oncology-based In-vivo CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Academic and Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oncology-based In-vivo CRO Market Perspective (2020-2031)
2.2 Global Oncology-based In-vivo CRO Growth Trends by Region
2.2.1 Global Oncology-based In-vivo CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Oncology-based In-vivo CRO Historic Market Size by Region (2020-2025)
2.2.3 Oncology-based In-vivo CRO Forecasted Market Size by Region (2026-2031)
2.3 Oncology-based In-vivo CRO Market Dynamics
2.3.1 Oncology-based In-vivo CRO Industry Trends
2.3.2 Oncology-based In-vivo CRO Market Drivers
2.3.3 Oncology-based In-vivo CRO Market Challenges
2.3.4 Oncology-based In-vivo CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncology-based In-vivo CRO Players by Revenue
3.1.1 Global Top Oncology-based In-vivo CRO Players by Revenue (2020-2025)
3.1.2 Global Oncology-based In-vivo CRO Revenue Market Share by Players (2020-2025)
3.2 Global Top Oncology-based In-vivo CRO Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Oncology-based In-vivo CRO Revenue
3.4 Global Oncology-based In-vivo CRO Market Concentration Ratio
3.4.1 Global Oncology-based In-vivo CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology-based In-vivo CRO Revenue in 2024
3.5 Global Key Players of Oncology-based In-vivo CRO Head office and Area Served
3.6 Global Key Players of Oncology-based In-vivo CRO, Product and Application
3.7 Global Key Players of Oncology-based In-vivo CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncology-based In-vivo CRO Breakdown Data by Type
4.1 Global Oncology-based In-vivo CRO Historic Market Size by Type (2020-2025)
4.2 Global Oncology-based In-vivo CRO Forecasted Market Size by Type (2026-2031)
5 Oncology-based In-vivo CRO Breakdown Data by Application
5.1 Global Oncology-based In-vivo CRO Historic Market Size by Application (2020-2025)
5.2 Global Oncology-based In-vivo CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Oncology-based In-vivo CRO Market Size (2020-2031)
6.2 North America Oncology-based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Oncology-based In-vivo CRO Market Size by Country (2020-2025)
6.4 North America Oncology-based In-vivo CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oncology-based In-vivo CRO Market Size (2020-2031)
7.2 Europe Oncology-based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Oncology-based In-vivo CRO Market Size by Country (2020-2025)
7.4 Europe Oncology-based In-vivo CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Oncology-based In-vivo CRO Market Size (2020-2031)
8.2 Asia-Pacific Oncology-based In-vivo CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Oncology-based In-vivo CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Oncology-based In-vivo CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Oncology-based In-vivo CRO Market Size (2020-2031)
9.2 Latin America Oncology-based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Oncology-based In-vivo CRO Market Size by Country (2020-2025)
9.4 Latin America Oncology-based In-vivo CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncology-based In-vivo CRO Market Size (2020-2031)
10.2 Middle East & Africa Oncology-based In-vivo CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Oncology-based In-vivo CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Oncology-based In-vivo CRO Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Oncology-based In-vivo CRO Introduction
11.1.4 Charles River Laboratories Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.1.5 Charles River Laboratories Recent Development
11.2 ICON
11.2.1 ICON Company Details
11.2.2 ICON Business Overview
11.2.3 ICON Oncology-based In-vivo CRO Introduction
11.2.4 ICON Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.2.5 ICON Recent Development
11.3 WuXi AppTec
11.3.1 WuXi AppTec Company Details
11.3.2 WuXi AppTec Business Overview
11.3.3 WuXi AppTec Oncology-based In-vivo CRO Introduction
11.3.4 WuXi AppTec Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.3.5 WuXi AppTec Recent Development
11.4 Crown Bioscience
11.4.1 Crown Bioscience Company Details
11.4.2 Crown Bioscience Business Overview
11.4.3 Crown Bioscience Oncology-based In-vivo CRO Introduction
11.4.4 Crown Bioscience Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.4.5 Crown Bioscience Recent Development
11.5 Labcorp Drug Development
11.5.1 Labcorp Drug Development Company Details
11.5.2 Labcorp Drug Development Business Overview
11.5.3 Labcorp Drug Development Oncology-based In-vivo CRO Introduction
11.5.4 Labcorp Drug Development Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.5.5 Labcorp Drug Development Recent Development
11.6 Eurofins Scientific
11.6.1 Eurofins Scientific Company Details
11.6.2 Eurofins Scientific Business Overview
11.6.3 Eurofins Scientific Oncology-based In-vivo CRO Introduction
11.6.4 Eurofins Scientific Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.6.5 Eurofins Scientific Recent Development
11.7 Taconic Biosciences
11.7.1 Taconic Biosciences Company Details
11.7.2 Taconic Biosciences Business Overview
11.7.3 Taconic Biosciences Oncology-based In-vivo CRO Introduction
11.7.4 Taconic Biosciences Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.7.5 Taconic Biosciences Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Oncology-based In-vivo CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.8.5 The Jackson Laboratory Recent Development
11.9 Evotec
11.9.1 Evotec Company Details
11.9.2 Evotec Business Overview
11.9.3 Evotec Oncology-based In-vivo CRO Introduction
11.9.4 Evotec Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.9.5 Evotec Recent Development
11.10 Champions Oncology
11.10.1 Champions Oncology Company Details
11.10.2 Champions Oncology Business Overview
11.10.3 Champions Oncology Oncology-based In-vivo CRO Introduction
11.10.4 Champions Oncology Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.10.5 Champions Oncology Recent Development
11.11 Thermo Fisher Scientific
11.11.1 Thermo Fisher Scientific Company Details
11.11.2 Thermo Fisher Scientific Business Overview
11.11.3 Thermo Fisher Scientific Oncology-based In-vivo CRO Introduction
11.11.4 Thermo Fisher Scientific Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.11.5 Thermo Fisher Scientific Recent Development
11.12 IMV
11.12.1 IMV Company Details
11.12.2 IMV Business Overview
11.12.3 IMV Oncology-based In-vivo CRO Introduction
11.12.4 IMV Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.12.5 IMV Recent Development
11.13 Pharmaron
11.13.1 Pharmaron Company Details
11.13.2 Pharmaron Business Overview
11.13.3 Pharmaron Oncology-based In-vivo CRO Introduction
11.13.4 Pharmaron Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.13.5 Pharmaron Recent Development
11.14 Living Tumor Laboratory
11.14.1 Living Tumor Laboratory Company Details
11.14.2 Living Tumor Laboratory Business Overview
11.14.3 Living Tumor Laboratory Oncology-based In-vivo CRO Introduction
11.14.4 Living Tumor Laboratory Revenue in Oncology-based In-vivo CRO Business (2020-2025)
11.14.5 Living Tumor Laboratory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Oncology-based In-vivo CRO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Efficacy Evaluation
Table 3. Key Players of Combination Therapy Testing
Table 4. Key Players of Tumor Immune Microenvironment Assessment
Table 5. Key Players of Others
Table 6. Global Oncology-based In-vivo CRO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Oncology-based In-vivo CRO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Oncology-based In-vivo CRO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Oncology-based In-vivo CRO Market Share by Region (2020-2025)
Table 10. Global Oncology-based In-vivo CRO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Oncology-based In-vivo CRO Market Share by Region (2026-2031)
Table 12. Oncology-based In-vivo CRO Market Trends
Table 13. Oncology-based In-vivo CRO Market Drivers
Table 14. Oncology-based In-vivo CRO Market Challenges
Table 15. Oncology-based In-vivo CRO Market Restraints
Table 16. Global Oncology-based In-vivo CRO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Oncology-based In-vivo CRO Market Share by Players (2020-2025)
Table 18. Global Top Oncology-based In-vivo CRO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology-based In-vivo CRO as of 2024)
Table 19. Ranking of Global Top Oncology-based In-vivo CRO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Oncology-based In-vivo CRO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Oncology-based In-vivo CRO, Headquarters and Area Served
Table 22. Global Key Players of Oncology-based In-vivo CRO, Product and Application
Table 23. Global Key Players of Oncology-based In-vivo CRO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oncology-based In-vivo CRO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Oncology-based In-vivo CRO Revenue Market Share by Type (2020-2025)
Table 27. Global Oncology-based In-vivo CRO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Oncology-based In-vivo CRO Revenue Market Share by Type (2026-2031)
Table 29. Global Oncology-based In-vivo CRO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Oncology-based In-vivo CRO Revenue Market Share by Application (2020-2025)
Table 31. Global Oncology-based In-vivo CRO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Oncology-based In-vivo CRO Revenue Market Share by Application (2026-2031)
Table 33. North America Oncology-based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Oncology-based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Oncology-based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Oncology-based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Oncology-based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Oncology-based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Oncology-based In-vivo CRO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Oncology-based In-vivo CRO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Oncology-based In-vivo CRO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Oncology-based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Oncology-based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Oncology-based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Oncology-based In-vivo CRO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Oncology-based In-vivo CRO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Oncology-based In-vivo CRO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Charles River Laboratories Company Details
Table 49. Charles River Laboratories Business Overview
Table 50. Charles River Laboratories Oncology-based In-vivo CRO Product
Table 51. Charles River Laboratories Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 52. Charles River Laboratories Recent Development
Table 53. ICON Company Details
Table 54. ICON Business Overview
Table 55. ICON Oncology-based In-vivo CRO Product
Table 56. ICON Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 57. ICON Recent Development
Table 58. WuXi AppTec Company Details
Table 59. WuXi AppTec Business Overview
Table 60. WuXi AppTec Oncology-based In-vivo CRO Product
Table 61. WuXi AppTec Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 62. WuXi AppTec Recent Development
Table 63. Crown Bioscience Company Details
Table 64. Crown Bioscience Business Overview
Table 65. Crown Bioscience Oncology-based In-vivo CRO Product
Table 66. Crown Bioscience Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 67. Crown Bioscience Recent Development
Table 68. Labcorp Drug Development Company Details
Table 69. Labcorp Drug Development Business Overview
Table 70. Labcorp Drug Development Oncology-based In-vivo CRO Product
Table 71. Labcorp Drug Development Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 72. Labcorp Drug Development Recent Development
Table 73. Eurofins Scientific Company Details
Table 74. Eurofins Scientific Business Overview
Table 75. Eurofins Scientific Oncology-based In-vivo CRO Product
Table 76. Eurofins Scientific Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 77. Eurofins Scientific Recent Development
Table 78. Taconic Biosciences Company Details
Table 79. Taconic Biosciences Business Overview
Table 80. Taconic Biosciences Oncology-based In-vivo CRO Product
Table 81. Taconic Biosciences Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 82. Taconic Biosciences Recent Development
Table 83. The Jackson Laboratory Company Details
Table 84. The Jackson Laboratory Business Overview
Table 85. The Jackson Laboratory Oncology-based In-vivo CRO Product
Table 86. The Jackson Laboratory Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 87. The Jackson Laboratory Recent Development
Table 88. Evotec Company Details
Table 89. Evotec Business Overview
Table 90. Evotec Oncology-based In-vivo CRO Product
Table 91. Evotec Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 92. Evotec Recent Development
Table 93. Champions Oncology Company Details
Table 94. Champions Oncology Business Overview
Table 95. Champions Oncology Oncology-based In-vivo CRO Product
Table 96. Champions Oncology Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 97. Champions Oncology Recent Development
Table 98. Thermo Fisher Scientific Company Details
Table 99. Thermo Fisher Scientific Business Overview
Table 100. Thermo Fisher Scientific Oncology-based In-vivo CRO Product
Table 101. Thermo Fisher Scientific Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 102. Thermo Fisher Scientific Recent Development
Table 103. IMV Company Details
Table 104. IMV Business Overview
Table 105. IMV Oncology-based In-vivo CRO Product
Table 106. IMV Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 107. IMV Recent Development
Table 108. Pharmaron Company Details
Table 109. Pharmaron Business Overview
Table 110. Pharmaron Oncology-based In-vivo CRO Product
Table 111. Pharmaron Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 112. Pharmaron Recent Development
Table 113. Living Tumor Laboratory Company Details
Table 114. Living Tumor Laboratory Business Overview
Table 115. Living Tumor Laboratory Oncology-based In-vivo CRO Product
Table 116. Living Tumor Laboratory Revenue in Oncology-based In-vivo CRO Business (2020-2025) & (US$ Million)
Table 117. Living Tumor Laboratory Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Oncology-based In-vivo CRO Picture
Figure 2. Global Oncology-based In-vivo CRO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Oncology-based In-vivo CRO Market Share by Type: 2024 VS 2031
Figure 4. Efficacy Evaluation Features
Figure 5. Combination Therapy Testing Features
Figure 6. Tumor Immune Microenvironment Assessment Features
Figure 7. Others Features
Figure 8. Global Oncology-based In-vivo CRO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Oncology-based In-vivo CRO Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Academic and Research Institutions Case Studies
Figure 12. Others Case Studies
Figure 13. Oncology-based In-vivo CRO Report Years Considered
Figure 14. Global Oncology-based In-vivo CRO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Oncology-based In-vivo CRO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Oncology-based In-vivo CRO Market Share by Region: 2024 VS 2031
Figure 17. Global Oncology-based In-vivo CRO Market Share by Players in 2024
Figure 18. Global Oncology-based In-vivo CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 19. The Top 10 and 5 Players Market Share by Oncology-based In-vivo CRO Revenue in 2024
Figure 20. North America Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Oncology-based In-vivo CRO Market Share by Country (2020-2031)
Figure 22. United States Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Oncology-based In-vivo CRO Market Share by Country (2020-2031)
Figure 26. Germany Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Ireland Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Oncology-based In-vivo CRO Market Share by Region (2020-2031)
Figure 34. China Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia & New Zealand Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Oncology-based In-vivo CRO Market Share by Country (2020-2031)
Figure 42. Mexico Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Oncology-based In-vivo CRO Market Share by Country (2020-2031)
Figure 46. Israel Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Oncology-based In-vivo CRO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Charles River Laboratories Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 50. ICON Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 51. WuXi AppTec Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 52. Crown Bioscience Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 53. Labcorp Drug Development Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 54. Eurofins Scientific Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 55. Taconic Biosciences Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 56. The Jackson Laboratory Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 57. Evotec Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 58. Champions Oncology Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 60. IMV Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 61. Pharmaron Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 62. Living Tumor Laboratory Revenue Growth Rate in Oncology-based In-vivo CRO Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
